GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evaxion Biotech AS (NAS:EVAX) » Definitions » 5-Year Yield-on-Cost %

EVAX (Evaxion Biotech AS) 5-Year Yield-on-Cost % : 0.00 (As of Apr. 17, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Evaxion Biotech AS 5-Year Yield-on-Cost %?

Evaxion Biotech AS's yield on cost for the quarter that ended in Dec. 2024 was 0.00.


The historical rank and industry rank for Evaxion Biotech AS's 5-Year Yield-on-Cost % or its related term are showing as below:



EVAX's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.65
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Evaxion Biotech AS's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Evaxion Biotech AS's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evaxion Biotech AS's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evaxion Biotech AS's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Evaxion Biotech AS's 5-Year Yield-on-Cost % falls into.


;
;

Evaxion Biotech AS 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Evaxion Biotech AS is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Evaxion Biotech AS  (NAS:EVAX) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Evaxion Biotech AS 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Evaxion Biotech AS's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Evaxion Biotech AS Business Description

Traded in Other Exchanges
N/A
Address
Dr. Neergaards Vej 5f, Hoersholm, DNK, DK-2970
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.